Table 3.
Details of Patients Referred for Tumor Board Evaluation and Tumor Board Recommendation, January 1, 2020 to July 30, 2020
Variable | Pre COVID-19 period (n = 53) | COVID-19 period (n = 34) | p Value |
---|---|---|---|
Nodule size, mm, mean ± SD | 14.5 ± 16.4 | 10.5 ± 7.1 | 0.56 |
New nodule, size | 16.5 ± 19.0 | 8.1 ± 4.0 | 0.11 |
Follow-up, Δ | 2.1 ± 1.9 | 2.5 ± 2.8 | 0.84 |
Interval scan, mo, mean ± SD | 13.6 ± 13.2 | 11.7 ± 14.1 | 0.36 |
Indication for tumor board, n (%) | <0.01 | ||
New nodule | 37 (69.8) | 10 (38.5) | |
Enlarging nodule | 16 (30.2) | 16 (61.5) | |
Tumor board recommendation, n (%) | 0.04 | ||
Repeat imaging | 41 (78.9) | 14 (56.0) | |
Intervention | 11 (21.2) | 11 (44.0) |
Δ, change.